Company Profile

ANI Pharmaceuticals Stock Price, News & Catalysts

Ticker:
ANIP
Exchange:
NASDAQ
Sector:
Biopharma
Location:
United States

Stock performance

69.13 USD (-3.27%)

Close

Last updated: November 19, 2026

1.7B USD

Market cap

Why the stock is moving

Following the latest company update, “ANI Pharmaceuticals to Present at Upcoming December Investor Conference”, ANIP closed down 3.27% at $69.13 on Nov 19, 2026. The move occurred in the trading session associated with this conference / presentation update.

Company overview

Rare-Disease and Specialty Pharmaceuticals

ANI Pharmaceuticals develops and commercializes medicines across rare disease, ophthalmology and established pharmaceutical markets. Its model combines branded specialty products with a portfolio of generic medicines.

Cortrophin Gel

Purified Cortrophin Gel is an adrenocorticotropic hormone therapy used across selected autoimmune and inflammatory indications. It is the primary growth driver of ANI's rare-disease franchise.

Ophthalmology Portfolio

ILUVIEN and YUTIQ are sustained-release fluocinolone implants for retinal diseases, including diabetic macular edema and chronic noninfectious uveitis affecting the posterior segment.

Clinical Evidence Strategy

The Phase 4 SYNCHRONICITY program evaluates real-world visual and anatomical outcomes with the fluocinolone acetonide implant in chronic noninfectious uveitis. Post-approval evidence supports ophthalmologist education and differentiation of ANI's long-duration retinal therapy.

Future catalysts

    Recent news

    1. 01
    2. 02
    3. 03
    4. 04
    5. 05

    Similar stocks

    Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.

    Frequently Asked Questions

    What is the current stock price of ANI Pharmaceuticals (ANIP)?

    ANI Pharmaceuticals (ANIP) most recently closed at 69.13 USD, a -3.27% move versus the previous session.

    What is the market cap of ANI Pharmaceuticals (ANIP)?

    ANI Pharmaceuticals currently has a market capitalization of 1.7B USD on BioPharmSignal.

    What does ANI Pharmaceuticals do?

    Rare-Disease and Specialty Pharmaceuticals ANI Pharmaceuticals develops and commercializes medicines across rare disease, ophthalmology and established pharmaceutical markets. Its model combines branded specialty products with a portfolio of generic medicines. Cortrophin Gel Purified Cortrophin Gel is an adrenocorticotropic hormone therapy used across...

    On which exchange is ANIP stock listed?

    ANI Pharmaceuticals (ANIP) is associated with NASDAQ, United States, Biopharma.

    What is Rare-Disease?

    Rare-Disease and Specialty Pharmaceuticals ANI Pharmaceuticals develops and commercializes medicines across rare disease, ophthalmology and established pharmaceutical markets.

    Which conditions is ANI Pharmaceuticals targeting with Rare-Disease?

    ANI Pharmaceuticals is associated with rare disease, ophthalmology based on its company overview and current catalyst commentary.

    What is Specialty?

    Rare-Disease and Specialty Pharmaceuticals ANI Pharmaceuticals develops and commercializes medicines across rare disease, ophthalmology and established pharmaceutical markets.

    What is Pharmaceuticals?

    Rare-Disease and Specialty Pharmaceuticals ANI Pharmaceuticals develops and commercializes medicines across rare disease, ophthalmology and established pharmaceutical markets.